Dendritic Cell Based Therapy of Renal Cell Carcinoma
|針對症狀||Advanced Renal Cell Carcinoma|
|臨床試驗位址||Department of Oncology, Copenhagen University Hospital, Herlev|
|目前研究進度||This study has been completed.|
|試驗開始日期||September 20, 2005|
|試驗開始日期||November 23, 2011|
The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with peptides or tumor lysate in combination with adjuvant cytokines can induce a measurable immune response in patients with metastatic renal cell carcinoma, and to evaluate the clinical effect (objective response rate) of the vaccination regime.